PUBLISHER: The Business Research Company | PRODUCT CODE: 2036108
PUBLISHER: The Business Research Company | PRODUCT CODE: 2036108
Sternal closure devices are surgical tools intended to rejoin and stabilize the sternum after it has been separated during procedures like open-heart surgery. Their key function is to secure the bone, support effective healing, maintain chest wall integrity, and reduce the risk of complications such as sternal dehiscence or postoperative infections.
The key product types of sternal closure devices include wire cerclage, plate and screw systems, cable systems, clips, and other variants. Wire cerclage devices stabilize and close the sternum after cardiac or thoracic surgery, ensuring proper healing and reducing postoperative complications. They are made from stainless steel, titanium, polyether ether ketone (PEEK), and other materials. Procedures include median sternotomy, hemisternotomy, and bilateral thoracosternotomy, serving hospitals, cardiac centers, ambulatory surgical centers, and other end users.
Tariffs have influenced the sternal closure devices market by raising the cost of importing high-grade materials, advanced instruments, and implantable devices. This impact is most notable in segments like plate and screw systems and cable systems, especially in regions such as North America and Europe that depend on imported surgical hardware. While tariffs have temporarily increased costs, they have also incentivized local manufacturing and encouraged innovation in cost-effective, domestically produced closure solutions, fostering long-term market resilience and diversification.
The sternal closure devices market research report is one of a series of new reports from The Business Research Company that provides sternal closure devices market statistics, including sternal closure devices industry global market size, regional shares, competitors with a sternal closure devices market share, detailed sternal closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the sternal closure devices industry. This sternal closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sternal closure devices market size has grown strongly in recent years. It will grow from $2.01 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising number of open-heart surgeries, adoption of traditional wire cerclage techniques, increasing awareness of postoperative complications, growth of cardiac care infrastructure, demand for reliable sternal stabilization.
The sternal closure devices market size is expected to see strong growth in the next few years. It will grow to $2.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to innovation in bioabsorbable and hybrid closure systems, adoption of patient-specific titanium and peek devices, integration with digital surgical planning tools, demand for enhanced postoperative recovery monitoring, expansion of ambulatory surgical centers. Major trends in the forecast period include minimally invasive sternal closure techniques, patient-specific sternal fixation devices, advanced biocompatible materials, integration with surgical navigation systems, postoperative monitoring and analytics.
The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the sternal closure devices market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, and stroke, which disrupt normal circulatory function. The rise in cardiovascular diseases is attributed to greater exposure to unhealthy lifestyle habits, such as physical inactivity, which heighten cardiac risk and increase the number of patients requiring surgical interventions. Sternal closure devices are used to secure the sternum after open-heart surgeries, facilitating proper bone healing, maintaining chest stability, and reducing the risk of infection, instability, and delayed recovery to improve overall postoperative outcomes for cardiovascular patients. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, deaths from cardiovascular disease rose from 371,506 cases in 2022 to 919,032 deaths in 2023. Consequently, this growing prevalence of cardiovascular diseases is propelling the expansion of the sternal closure devices market.
Leading companies operating in the sternal closure devices market are focusing on developing advanced rigid fixation solutions to enhance chest stability, reduce postoperative complications, and accelerate patient recovery after cardiac procedures. Rigid sternal fixation systems refer to implantable plating and screw-based devices that stabilize the sternum following median sternotomy, improving bone healing and minimizing the risk of sternal dehiscence. For example, in August 2024, DePuy Synthes, a US-based medical device company, launched the MatrixSTERNUM Fixation System to provide enhanced sternal stability after open-heart surgery. The system features titanium plates and locking screw technology designed to deliver strong, reliable fixation, support bone healing, and reduce movement at the surgical site, thereby improving clinical outcomes and patient safety following cardiac surgery.
The rising number of cardiac surgery procedures is expected to further boost the growth of the sternal closure devices market. Cardiac surgery procedures involve operative interventions on the heart and its surrounding structures to address conditions such as coronary artery disease, valvular disorders, and congenital heart defects. The increase in surgical procedures is largely driven by the growing prevalence of chronic diseases linked to aging populations and lifestyle-related health issues. This surge in cardiac surgeries directly elevates the demand for sternal closure devices, as each open-heart surgery with a median sternotomy necessitates secure and reliable sternal closure to support healing and prevent postoperative complications. For instance, in March 2025, according to The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database, a US-based clinical registry covering over 97% of cardiac surgeries performed in the United States, overall cardiac surgical volumes grew by 4.2% in 2023 compared with 2022, reflecting a continued post-pandemic recovery in surgical activity nationwide. Therefore, the rising cardiac surgery procedures are contributing to the growth of the sternal closure devices market.
Major companies operating in the sternal closure devices market are Stryker Corporation, B. Braun, Zimmer Biomet Holdings Inc., Arthrex Inc., Teleflex Incorporated, KLS Martin SE & Co. KG, Acumed LLC, Peters Surgical, DePuy Synthes, J.J.A.C.E. Ltd, Medicon eG, Kinamed Incorporated, ABYRX Inc., Jeil Medical Corporation, Able Medical Devices, Neos Surgery S.L., Praesidia S.R.L., MedXpert GmbH, Investigaciones y Desarrollos Argentinos S.R.L., Changzhou Waston Medical Appliance Co. Ltd., Dispomedica GmbH.
North America was the largest region in the sternal closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sternal closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sternal closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sternal closure devices market consists of sales of sternal locking bands, bioresorbable sternal fixation devices, sternal bone adhesive systems, and titanium sternal reinforcement meshes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sternal Closure Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sternal closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sternal closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sternal closure devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.